SELLAS Life Sciences Group (SLS) Short Interest Ratio & Short Volume → The only AI company to buy (From Porter & Company) (Ad) Free SLS Stock Alerts $1.39 +0.04 (+2.96%) (As of 11:21 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends SELLAS Life Sciences Group Short Interest DataCurrent Short Interest7,250,000 sharesPrevious Short Interest6,990,000 sharesChange Vs. Previous Month+3.72%Dollar Volume Sold Short$10.66 millionShort Interest Ratio4.7 Days to CoverLast Record DateMay 15, 2024Outstanding Shares57,760,000 sharesPercentage of Shares Shorted12.55%Today's Trading Volume154,831 sharesAverage Trading Volume1,418,125 sharesToday's Volume Vs. Average11% Short Selling SELLAS Life Sciences Group ? Sign up to receive the latest short interest report for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSLS Short Interest Over TimeSLS Days to Cover Over TimeSLS Percentage of Float Shorted Over Time Ad Porter & CompanyThe only AI company to buyThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. SELLAS Life Sciences Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20247,250,000 shares $10.66 million +3.7%N/A4.7 $1.47 4/30/20246,990,000 shares $8.67 million +23.3%N/A4.6 $1.24 4/15/20245,670,000 shares $7.54 million +7.6%N/A4 $1.33 3/31/20245,270,000 shares $5.32 million +1.7%N/A3.6 $1.01 3/15/20245,180,000 shares $5.70 million +14.9%N/A3.7 $1.10 2/29/20244,510,000 shares $4.56 million +15.9%N/A4.2 $1.01 Get the Latest News and Ratings for SLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE daily newsletter. 2/15/20243,890,000 shares $2.74 million +24.7%N/A3.7 $0.70 1/31/20243,120,000 shares $2.00 million -19.6%N/A3.1 $0.64 1/15/20243,880,000 shares $2.07 million -18.0%N/A4.3 $0.53 12/31/20234,730,000 shares $5.01 million +1.5%N/A4.9 $1.06 12/15/20234,660,000 shares $5.36 million +1.1%N/A6.3 $1.15 11/30/20234,610,000 shares $4.79 million +0.7%N/A7.3 $1.04 11/15/20234,580,000 shares $4.44 million +50.2%N/A8.7 $0.97 10/31/20233,050,000 shares $2.96 million +49.5%N/A6.6 $0.97 10/15/20232,040,000 shares $2.65 million +87.2%N/A6.5 $1.30 9/30/20231,090,000 shares $1.79 million +6.9%N/A7.7 $1.64 9/15/20231,020,000 shares $1.64 million -9.7%N/A8.1 $1.61 8/31/20231,130,000 shares $1.66 million No ChangeN/A8.9 $1.47 8/15/20231,130,000 shares $1.68 million -4.2%N/A8.7 $1.49 7/31/20231,180,000 shares $1.94 million +2.6%N/A8.2 $1.64 7/15/20231,150,000 shares $1.97 million -0.9%N/A7.4 $1.71 6/30/20231,160,000 shares $1.82 million +3.6%N/A6.8 $1.57 6/15/20231,120,000 shares $1.86 million -5.9%N/A5.4 $1.66 5/31/20231,190,000 shares $2.04 million -4.8%N/A4.8 $1.72 5/15/20231,250,000 shares $2.05 million +4.2%N/A2.7 $1.64 4/30/20231,200,000 shares $1.69 million +1.7%N/A2.6 $1.41 4/15/20231,180,000 shares $1.89 million +7.3%N/A2.6 $1.60 3/31/20231,100,000 shares $1.57 million -9.8%N/A2.4 $1.43 3/15/20231,220,000 shares $1.68 million -5.4%N/A3 $1.38 2/28/20231,290,000 shares $2.18 million +7.5%N/A3.5 $1.69 2/15/20231,200,000 shares $3.79 million +2.6%N/A4.1 $3.16 1/31/20231,170,000 shares $3.88 million -2.5%N/A4.5 $3.32 1/15/20231,200,000 shares $3.41 million -3.2%N/A3.6 $2.84 12/30/20221,240,000 shares $2.93 million +0.8%N/A3.3 $2.36 12/15/20221,230,000 shares $2.85 million +1.7%N/A3.4 $2.32 11/30/20221,210,000 shares $2.89 million +5.2%N/A3.3 $2.39 11/15/20221,150,000 shares $2.58 million +15.4%N/A3.3 $2.24 10/31/2022996,800 shares $4.67 million +21.3%N/A3.8 $4.68 10/15/2022822,000 shares $1.57 million -0.9%N/A4.5 $1.91 9/30/2022829,600 shares $1.68 million -0.7%N/A8.3 $2.02The only AI company to buy (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. 9/15/2022835,100 shares $2.51 million +0.1%N/A7.8 $3.00 8/31/2022834,400 shares $2.55 million -6.1%N/A7.1 $3.06 8/15/2022888,700 shares $2.88 million +5.9%N/A6.6 $3.24 7/31/2022838,900 shares $2.15 million -2.3%N/A5.4 $2.56 7/15/2022858,900 shares $2.16 million -4.1%N/A5.3 $2.52 6/30/2022895,600 shares $2.00 million -0.3%N/A4.7 $2.23 6/15/2022897,800 shares $2.22 million +6.0%N/A3 $2.47 5/31/2022847,000 shares $2.58 million -10.1%N/A3 $3.05 5/15/2022942,500 shares $2.51 million +8.6%N/A3.4 $2.66 4/30/2022867,800 shares $2.36 million -5.2%N/A3.5 $2.72 4/15/2022915,500 shares $3.22 million -8.5%N/A3.5 $3.52 3/31/20221,000,000 shares $6.68 million No ChangeN/A4 $6.68 3/15/20221,000,000 shares $5.38 million +1.2%N/A7.3 $5.38 2/28/2022988,000 shares $6.03 million -1.1%N/A7 $6.10 2/15/2022999,200 shares $6.48 million +1.3%N/A7.1 $6.49 1/31/2022986,700 shares $5.27 million +15.4%N/A5.8 $5.34 1/15/2022854,700 shares $4.73 million +10.0%N/A5.6 $5.53 12/31/2021776,800 shares $4.30 million -2.4%N/A5.1 $5.53 12/15/2021796,100 shares $5.10 million +9.6%N/A5.1 $6.40 11/30/2021726,200 shares $4.89 million +11.8%N/A4.4 $6.74 11/15/2021649,600 shares $4.85 million -3.5%N/A3.7 $7.47 10/29/2021672,900 shares $5.85 million -22.1%N/A3.7 $8.69 10/15/2021863,200 shares $7.62 million +4.1%N/A4.3 $8.83 9/30/2021829,200 shares $7.60 million +7.2%N/A3.6 $9.16 9/15/2021773,700 shares $7.78 million -14.2%N/A1.7 $10.05 8/31/2021901,200 shares $8.37 million -23.6%N/A1.8 $9.29 8/13/20211,180,000 shares $11.88 million No ChangeN/A2 $10.07 7/30/20211,180,000 shares $10.10 million +4.4%N/A2 $8.56 7/15/20211,130,000 shares $9.75 million +28.9%N/A1.9 $8.63 6/30/2021876,900 shares $9.73 million +27.3%N/A1.5 $11.10 6/15/2021688,900 shares $7.89 million -10.9%N/A1.4 $11.45 5/28/2021773,400 shares $9.25 million -15.2%N/A1.5 $11.96 5/14/2021911,600 shares $0.00 +1.2%6.1%1.7 $0.00 4/30/2021901,100 shares $7.22 million -4.2%6.1%1.4 $8.01 4/15/2021940,100 shares $7.76 million +20.2%6.3%0.5 $8.25 3/31/2021782,300 shares $6.27 million -8.2%5.3%0.4 $8.02 3/15/2021852,100 shares $8.74 million +5.9%6.1%0.4 $10.26 2/26/2021805,000 shares $6.74 million -16.2%5.8%0.1 $8.37 2/12/2021960,400 shares $8.85 million +5.2%6.9%0.2 $9.21 1/29/2021912,700 shares $5.02 million +43.4%8.1%0.2 $5.50 1/15/2021636,300 shares $3.85 million -15.4%5.6%0.2 $6.05 12/31/2020752,000 shares $4.39 million -40.3%6.7%0.2 $5.84 12/15/20201,260,000 shares $8.43 million +127.5%11.3%0.3 $6.69 11/30/2020553,900 shares $2.06 million +51.1%6.2%1.3 $3.72 11/15/2020366,600 shares $964,158.00 -11.1%4.1%2.3 $2.63 10/30/2020412,200 shares $1.08 million -0.1%4.6%2.9 $2.63 10/15/2020412,500 shares $1.10 million -1.6%4.6%2.1 $2.66 SLS Short Interest - Frequently Asked Questions What is SELLAS Life Sciences Group's current short interest? Short interest is the volume of SELLAS Life Sciences Group shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 7,250,000 shares of SLS short. Learn More on SELLAS Life Sciences Group's current short interest. What is a good short interest ratio for SELLAS Life Sciences Group? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLS shares currently have a short interest ratio of 5.0. Learn More on SELLAS Life Sciences Group's short interest ratio. Is SELLAS Life Sciences Group's short interest increasing or decreasing? SELLAS Life Sciences Group saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 7,250,000 shares, an increase of 3.7% from the previous total of 6,990,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does SELLAS Life Sciences Group's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to SELLAS Life Sciences Group: Eledon Pharmaceuticals, Inc. (0.77%), Cellectar Biosciences, Inc. (6.54%), Nanobiotix S.A. (0.12%), Atea Pharmaceuticals, Inc. (2.53%), Kamada Ltd. (0.11%), XOMA Co. (2.09%), ADC Therapeutics SA (1.36%), CorMedix Inc. (17.61%), Mersana Therapeutics, Inc. (7.35%), Vanda Pharmaceuticals Inc. (5.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short SELLAS Life Sciences Group stock? Short selling SLS is an investing strategy that aims to generate trading profit from SELLAS Life Sciences Group as its price is falling. SLS shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against SELLAS Life Sciences Group? A short squeeze for SELLAS Life Sciences Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SLS, which in turn drives the price of the stock up even further. How often is SELLAS Life Sciences Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLS, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ELDN Short Interest Data CLRB Short Interest Data NBTX Short Interest Data AVIR Short Interest Data KMDA Short Interest Data XOMA Short Interest Data ADCT Short Interest Data CRMD Short Interest Data MRSN Short Interest Data VNDA Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLS) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceThe 7th Trillion Dollar Company?The Oxford ClubThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyBUY ALERT: Tiny tech play partners with US governmentStansberry ResearchGold Set to EXPLODE!Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SELLAS Life Sciences Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.